GSTDTAP

浏览/检索结果: 共7条,第1-7条 帮助

已选(0)清除 条数/页:   排序方式:
Integrating genomic features for non-invasive early lung cancer detection 期刊论文
NATURE, 2020, 580 (7802) : 245-+
作者:  Wang, Qinyang;  Wang, Yupeng;  Ding, Jingjin;  Wang, Chunhong;  Zhou, Xuehan;  Gao, Wenqing;  Huang, Huanwei;  Shao, Feng;  Liu, Zhibo
收藏  |  浏览/下载:15/0  |  提交时间:2020/07/03

Circulating tumour DNA in blood is analysed to identify genomic features that distinguish early-stage lung cancer patients from risk-matched controls, and these are integrated into a machine-learning method for blood-based lung cancer screening.


Radiologic screening of high-risk adults reduces lung-cancer-related mortality(1,2)  however, a small minority of eligible individuals undergo such screening in the United States(3,4). The availability of blood-based tests could increase screening uptake. Here we introduce improvements to cancer personalized profiling by deep sequencing (CAPP-Seq)(5), a method for the analysis of circulating tumour DNA (ctDNA), to better facilitate screening applications. We show that, although levels are very low in early-stage lung cancers, ctDNA is present prior to treatment in most patients and its presence is strongly prognostic. We also find that the majority of somatic mutations in the cell-free DNA (cfDNA) of patients with lung cancer and of risk-matched controls reflect clonal haematopoiesis and are non-recurrent. Compared with tumour-derived mutations, clonal haematopoiesis mutations occur on longer cfDNA fragments and lack mutational signatures that are associated with tobacco smoking. Integrating these findings with other molecular features, we develop and prospectively validate a machine-learning method termed '  lung cancer likelihood in plasma'  (Lung-CLiP), which can robustly discriminate early-stage lung cancer patients from risk-matched controls. This approach achieves performance similar to that of tumour-informed ctDNA detection and enables tuning of assay specificity in order to facilitate distinct clinical applications. Our findings establish the potential of cfDNA for lung cancer screening and highlight the importance of risk-matching cases and controls in cfDNA-based screening studies.


  
Tobacco smoking and somatic mutations in human bronchial epithelium 期刊论文
NATURE, 2020, 578 (7794) : 266-+
作者:  Sharma, Nikhil;  Flaherty, Kali;  Lezgiyeva, Karina;  Wagner, Daniel E.;  Klein, Allon M.;  Ginty, David D.
收藏  |  浏览/下载:33/0  |  提交时间:2020/07/03

Whole-genome sequencing of normal bronchial epithelium from 16 individuals shows that tobacco smoking increases genomic heterogeneity, mutational burden and driver mutations, whereas stopping smoking promotes replenishment of the epithelium with near-normal cells.


Tobacco smoking causes lung cancer(1-3), a process that is driven by more than 60 carcinogens in cigarette smoke that directly damage and mutate DNA(4,5). The profound effects of tobacco on the genome of lung cancer cells are well-documented(6-10), but equivalent data for normal bronchial cells are lacking. Here we sequenced whole genomes of 632 colonies derived from single bronchial epithelial cells across 16 subjects. Tobacco smoking was the major influence on mutational burden, typically adding from 1,000 to 10,000 mutations per cell  massively increasing the variance both within and between subjects  and generating several distinct mutational signatures of substitutions and of insertions and deletions. A population of cells in individuals with a history of smoking had mutational burdens that were equivalent to those expected for people who had never smoked: these cells had less damage from tobacco-specific mutational processes, were fourfold more frequent in ex-smokers than current smokers and had considerably longer telomeres than their more-mutated counterparts. Driver mutations increased in frequency with age, affecting 4-14% of cells in middle-aged subjects who had never smoked. In current smokers, at least 25% of cells carried driver mutations and 0-6% of cells had two or even three drivers. Thus, tobacco smoking increases mutational burden, cell-to-cell heterogeneity and driver mutations, but quitting promotes replenishment of the bronchial epithelium from mitotically quiescent cells that have avoided tobacco mutagenesis.


  
Behavioral Fitness and Resilience: A Review of Relevant Constructs, Measures, and Links to Well-Being 科技报告
来源:Rand Corporation. 出版年: 2014
作者:  Sean Robson;  Nicholas Salcedo
收藏  |  浏览/下载:6/0  |  提交时间:2019/04/05
Sleep  Health and Wellness Promotion  Communities  Tobacco and Smoking  Alcohol  Military Personnel  United States Air Force  
Availability, accessibility, usage and regulatory environment for novel and emerging tobacco, nicotine or related products 科技报告
来源:Rand Corporation. 出版年: 2013
作者:  Ellen Nolte;  Annalijn Conklin;  Laura Brereton;  Claire Celia;  Simo Goshev;  Flavia Tsang;  Clemence Pasmans
收藏  |  浏览/下载:5/0  |  提交时间:2019/04/05
European Union  Tobacco and Smoking  Controlled Substances  Market Regulation  
Evaluation of the Arkansas Tobacco Settlement Program: Progress Through 2011 科技报告
来源:Rand Corporation. 出版年: 2012
作者:  John Engberg;  Deborah M. Scharf;  Susan L. Lovejoy;  Hao Yu;  Shannah Tharp-Gilliam
收藏  |  浏览/下载:5/0  |  提交时间:2019/04/05
Tobacco and Smoking  Substance Abuse Treatment  Economists  Arkansas  Substance Abuse  Health Care Program Evaluation  Health Care Access  Controlled Substances  Smoking Cessation  Health Disparities  
Assessing the impacts of Revising the Tobacco Products Directive: Study to support a DG SANCO Impact Assessment 科技报告
来源:Rand Corporation. 出版年: 2011
作者:  ꙸĿ뎈Ŀrds a competitive European Internet industrJan Tiessen;  Priscillia Hunt;  Claire Celia;  Mihaly Fazekas;  Han de Vries;  Laura Staetsky;  Stephanie Diepeveen;  Lila Rabinovich;  Helen Ridsdale;  Tom Ling
收藏  |  浏览/下载:2/0  |  提交时间:2019/04/05
侘ʳ뎈Ŀnile Delinquency  Recidivism  After-School Programs  Probation  Los Angeles  SuInternational Education  Science and TechHealth Economics  Tobacco and Smoking  Economists  Substance Use  Market Regulation  Substance Abuse  European Union  Controlled Su  
Evaluation of the Arkansas Tobacco Settlement Program: Progress During 2008 and 2009 科技报告
来源:Rand Corporation. 出版年: 2010
作者:  Dana Schultz;  Shannah Tharp-Gilliam;  Tamara Dubowitz;  Hao Yu;  Susan L. Lovejoy;  Andrea Phillips;  John Engberg
收藏  |  浏览/下载:8/0  |  提交时间:2019/04/05
Tobacco and Smoking  Economists  Arkansas  Substance Abuse  Health Care Program Evaluation  Health Care Access  Controlled Substances  Health Disparities  Smoking Cessation